Remifentanil Hydrochloride Injection shortage
Current 9 presentations · 3 manufacturers · first FDA posting Jun 28, 2022 · last update Oct 15, 2026
Manufacturers: Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc., Mylan Institutional, a Viatris Company
Stated reasons (per FDA): Demand increase for the drug
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-723-03) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted Jun 28, 2022 Updated Oct 6, 2026 |
| Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-724-05) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted Jun 28, 2022 Updated Oct 15, 2026 |
| Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-725-10) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted Jun 28, 2022 Updated Oct 15, 2026 |
| Remifentanil Hydrochloride, Injection, 1 mg per vial (NDC 0143-9391-10) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Demand increase for the drug | Estimated recovery: TBD | Posted Jun 28, 2022 Updated Oct 14, 2026 |
| Remifentanil Hydrochloride, Injection, 2 mg per vial (NDC 0143-9392-10) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Demand increase for the drug | Estimated recovery: TBD | Posted Jun 28, 2022 Updated Oct 14, 2026 |
| Remifentanil Hydrochloride, Injection, 5 mg per vial (NDC 0143-9393-10) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Demand increase for the drug | Estimated recovery: TBD | Posted Jun 28, 2022 Updated Oct 14, 2026 |
| Ultiva, Injection, 1 mg/1 mL (NDC 72078-034-01) | Mylan Institutional, a Viatris Company | Current Available |
— | Posted Jun 28, 2022 Updated Oct 5, 2026 | |
| Ultiva, Injection, 2 mg (NDC 72078-035-02) | Mylan Institutional, a Viatris Company | Current Available |
— | Posted Jun 28, 2022 Updated Oct 5, 2026 | |
| Ultiva, Injection, 5 mg (NDC 72078-036-05) | Mylan Institutional, a Viatris Company | Current Available |
— | Posted Jun 28, 2022 Updated Oct 5, 2026 |